Methodologies and strategies for the bioengineering of lantibiotics

Current Pharmaceutical Biotechnology

Volumn 12, Issue 8, 2011, Pages 1221-1230

  Nagao, Jun ichi ^a   Nishie, Mami ^b   Sonomoto, Kenji ^b  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cyclization; Dehydration; Lantibiotics; Modification enzyme; Peptide engineering; Unusual amino acid

Indexed keywords

ENZYME; LACTICIN 3147; LANB PROTEIN; LANC PROTEIN; LANM PROTEIN; LANT PROTEIN; LANTIBIOTIC; NISIN; NUKACIN ISK 1; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOENGINEERING; CYCLIZATION; DRUG ACTIVITY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING;

EID: 79960030559     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111796117355     Document Type: Article

References (67)

1. de Vos, W. M.; Kuipers, O. P.; van der Meer, J. R.; Siezen, R. J. Maturation pathway of nisin and other lantibiotics: posttranslationally modified antimicrobial peptides exported by grampositive bacteria. Mol. Microbiol., 1995, 17(3), 427-437.
2. Chatterjee, C.; Paul, M.; Xie, L.; van der Donk, W. A. Biosynthesis and mode of action of lantibiotics. Chem. Rev., 2005, 105(2), 633-684.
3. Nagao, J.; Asaduzzaman, S. M.; Aso, Y.; Okuda, K.; Nakayama, J.; Sonomoto, K. Lantibiotics: insight and foresight for new paradigm. J. Biosci. Bioeng., 2006, 102(3), 139-149.
4. Jung, G.; Sahl, H.-G. Nisin and novel lantibiotics. ESCOM Science Publishers B. V., 1991.
5. Pag, U.; Sahl, H.-G. Multiple activities in lantibiotics - models for the design of novel antibiotics? Curr. Pharm. Des., 2002, 8(9), 815-833.
6. Meyer, C.; Bierbaum, G.; Heidrich, C.; Reis, M.; Suling, J.; Iglesias-Wind, M. I.; Kempter, C.; Molitor, E.; Sahl, H.-G. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur. J. Biochem., 1995, 232(2), 478-489.
7. Uguen, P.; Le Pennec, J. P.; Dufour, A. Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM. J. Bacteriol., 2000, 182(18), 5262-5266.
8. Aso, Y.; Nagao, J.; Koga, H.; Okuda, K.; Kanemasa, Y.; Sashihara, T.; Nakayama, J.; Sonomoto, K. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. J. Biosci. Bioeng., 2004, 98(6), 429-436.
9. Xie, L.; Miller, L. M.; Chatterjee, C.; Averin, O.; Kelleher, N. L.; van der Donk, W. A. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science, 2004, 303(5658), 679-681.
10. Asaduzzaman, S. M.; Sonomoto, K. Lantibiotics: diverse activities and unique modes of action. J. Biosci. Bioeng., 2009, 107(5), 475-487.
11. Lubelski, J.; Rink, R.; Khusainov, R.; Moll, G. N.; Kuipers, O. P. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol. Life Sci., 2008, 65(3), 455-476.
12. Siegers, K.; Heinzmann, S.; Entian, K. D. Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex. J. Biol. Chem., 1996, 271(21), 12294-12301.
13. Kiesau, P.; Eikmanns, U.; Gutowski-Eckel, Z.; Weber, S.; Hammelmann, M.; Entian, K. D. Evidence for a multimeric subtilin synthetase complex. J. Bacteriol., 1997, 179(5), 1475-1481.
14. Nagao, J.; Aso, Y.; Sashihara, T.; Shioya, K.; Adachi, A.; Nakayama, J.; Sonomoto, K. Localization and interaction of the biosynthetic proteins for the lantibiotic, Nukacin ISK-1. Biosci. Biotechnol. Biochem., 2005, 69(7), 1341-1347.
15. Chatterjee, C.; Patton, G. C.; Cooper, L.; Paul, M.; van der Donk, W. A. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase. Chem. Biol., 2006, 13(10), 1109-1117.
16. Kluskens, L. D.; Kuipers, A.; Rink, R.; de Boef, E.; Fekken, S.; Driessen, A. J.; Kuipers, O. P.; Moll, G. N. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin. Biochemistry, 2005, 44(38), 12827-12834.
17. Rink, R.; Kluskens, L. D.; Kuipers, A.; Driessen, A. J.; Kuipers, O. P.; Moll, G. N. NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides. Biochemistry, 2007, 46(45), 13179-13189.
18. Rink, R.; Kuipers, A.; de Boef, E.; Leenhouts, K. J.; Driessen, A. J.; Moll, G. N.; Kuipers, O. P. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochemistry, 2005, 44(24), 8873-8882.
19. Lubelski, J.; Overkamp, W.; Kluskens, L. D.; Moll, G. N.; Kuipers, O. P. Influence of shifting positions of Ser, Thr, and Cys residues in prenisin on the efficiency of modification reactions and on the antimicrobial activities of the modified prepeptides. Appl. Environ. Microbiol., 2008, 74(15), 4680-4685.
20. Li, B.; Yu, J. P.; Brunzelle, J. S.; Moll, G. N.; van der Donk, W. A.; Nair, S. K. Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science, 2006, 311(5766), 1464-1467.
21. Okeley, N. M.; Paul, M.; Stasser, J. P.; Blackburn, N.; van der Donk, W. A. SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins. Biochemistry, 2003, 42(46), 13613-13624.
22. Li, B.; van der Donk, W. A. Identification of essential catalytic residues of the cyclase NisC involved in the biosynthesis of nisin. J. Biol. Chem., 2007, 282(29), 21169-21175.
23. Lubelski, J.; Khusainov, R.; Kuipers, O. P. Directionality and coordination of dehydration and ring formation during biosynthesis of the lantibiotic nisin. J. Biol. Chem., 2009, 284(38), 25962-25972.
24. McClerren, A. L.; Cooper, L. E.; Quan, C.; Thomas, P. M.; Kelleher, N. L.; van der Donk, W. A. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA, 2006, 103(46), 17243-17248.
25. Chatterjee, C.; Miller, L. M.; Leung, Y. L.; Xie, L.; Yi, M.; Kelleher, N. L.; van der Donk, W. A. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production. J. Am. Chem. Soc., 2005, 127(44), 15332-15333.
26. Paul, M.; Patton, G. C.; van der Donk, W. A. Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity. Biochemistry, 2007, 46(21), 6268-6276.
27. Patton, G. C.; Paul, M.; Cooper, L. E.; Chatterjee, C.; van der Donk, W. A. The importance of the leader sequence for directing lanthionine formation in lacticin 481. Biochemistry, 2008, 47(28), 7342-7351.
28. Nagao, J.; Morinaga, Y.; Islam, M. R.; Asaduzzaman, S. M.; Aso, Y.; Nakayama, J.; Sonomoto, K. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide. Peptides, 2009, 30(8), 1412-1420.
29. Lee, M. V.; Ihnken, L. A.; You, Y. O.; McClerren, A. L.; van der Donk, W. A.; Kelleher, N. L. Distributive and directional behavior of lantibiotic synthetases revealed by high-resolution tandem mass spectrometry. J. Am. Chem. Soc., 2009, 131(34), 12258-12264.
30. Li, B.; Cooper, L. E.; van der Donk, W. A. In vitro studies of lantibiotic biosynthesis. Methods Enzymol., 2009, 458, 533-558.
31. Zhang, X.; Ni, W.; van der Donk, W. A. On the regioselectivity of thioether formation by lacticin 481 synthetase. Org. Lett., 2007, 9(17), 3343-3346.
32. Zhang, X.; van der Donk, W. A. Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases. Methods Enzymol., 2009, 462, 117-134.
33. Majchrzykiewicz, J. A.; Lubelski, J.; Moll, G. N.; Kuipers, A.; Bijlsma, J. J.; Kuipers, O. P.; Rink, R. Production of a class II twocomponent lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence. Antimicrob. Agents Chemother., 2010, 54(4), 1498-1505.
34. Chakicherla, A.; Hansen, J. N. Role of the leader and structural regions of prelantibiotic peptides as assessed by expressing nisinsubtilin chimeras in Bacillus subtilis 168, and characterization of their physical, chemical, and antimicrobial properties. J. Biol. Chem., 1995, 270(40), 23533-23539.
35. Breukink, E.; Wiedemann, I.; van Kraaij, C.; Kuipers, O. P.; Sahl, H.-G.; de Kruijff, B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science, 1999, 286(5448), 2361-2364.
36. Wiedemann, I.; Breukink, E.; van Kraaij, C.; Kuipers, O. P.; Bierbaum, G.; de Kruijff, B.; Sahl, H.-G. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem., 2001, 276(3), 1772-1779.
37. Hsu, S. T.; Breukink, E.; Tischenko, E.; Lutters, M. A.; de Kruijff, B.; Kaptein, R.; Bonvin, A. M.; van Nuland, N. A. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol., 2004, 11(10), 963-967.
38. Rollema, H. S.; Kuipers, O. P.; Both, P.; de Vos, W. M.; Siezen, R. J. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol., 1995, 61(8), 2873-2878.
39. Kuipers, O. P.; Bierbaum, G.; Ottenwälder, B.; Dodd, H. M.; Horn, N.; Metzger, J.; Kupke, T.; Gnau, V.; Bongers, R.; van den Bogaard, P.; Kosters, H.; Rollema, H. S.; de Vos, W. M.; Siezen, R. J.; Jung, G.; Götz, F.; Sahl, H.-G.; Gasson, M. J. Protein engineering of lantibiotics. Antonie van Leeuwenhoek, 1996, 69(2), 161-170.
40. Yuan, J.; Zhang, Z. Z.; Chen, X. Z.; Yang, W.; Huan, L. D. Sitedirected mutagenesis of the hinge region of nisin Z and properties of nisin Z mutants. Appl. Microbiol. Biotechnol., 2004, 64(6), 806-815.
41. Field, D.; Connor, P. M.; Cotter, P. D.; Hill, C.; Ross, R. P. The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol., 2008, 69(1), 218-230.
42. Rink, R.; Wierenga, J.; Kuipers, A.; Kluskens, L. D.; Driessen, A. J.; Kuipers, O. P.; Moll, G. N. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol., 2007, 73(18), 5809-5816.
43. van den Berg Saparoea, H. B.; Bakkes, P. J.; Moll, G. N.; Driessen, A. J. Distinct contributions of the nisin biosynthesis enzymes NisB and NisC and transporter NisT to prenisin production by Lactococcus lactis. Appl. Environ. Microbiol., 2008, 74(17), 5541-5548.
44. Kuipers, A.; Wierenga, J.; Rink, R.; Kluskens, L. D.; Driessen, A. J.; Kuipers, O. P.; Moll, G. N. Sec-mediated transport of posttranslationally dehydrated peptides in Lactococcus lactis. Appl. Environ. Microbiol., 2006, 72(12), 7626-7633.
45. Kuipers, A.; Rink, R.; Moll, G. N. Translocation of a thioetherbridged azurin peptide fragment via the sec pathway in Lactococcus lactis. Appl. Environ. Microbiol., 2009, 75(11), 3800-3802.
46. Kluskens, L. D.; Nelemans, S. A.; Rink, R.; de Vries, L.; Meter- Arkema, A.; Wang, Y.; Walther, T.; Kuipers, A.; Moll, G. N.; Haas, M. Angiotensin-(1-7) with thioether bridge: an angiotensinconverting enzyme-resistant, potent angiotensin-(1-7) analog. J. Pharmacol. Exp. Ther., 2009, 328(3), 849-854.
47. Wiedemann, I.; Bottiger, T.; Bonelli, R. R.; Wiese, A.; Hagge, S. O.; Gutsmann, T.; Seydel, U.; Deegan, L.; Hill, C.; Ross, P.; Sahl, H.-G. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol., 2006, 61(2), 285-296.
48. 2+ ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif. Appl. Environ. Microbiol., 2009, 75(13), 4427-4434.
49. Cotter, P. D.; Deegan, L. H.; Lawton, E. M.; Draper, L. A.; O'Connor, P. M.; Hill, C.; Ross, R. P. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol. Microbiol., 2006, 62(3), 735-747.
50. Field, D.; Collins, B.; Cotter, P. D.; Hill, C.; Ross, R. P. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities. J. Mol. Microbiol. Biotechnol., 2007, 13(4), 226-234.
51. Jack, R.; Benz, R.; Tagg, J.; Sahl, H.-G. The mode of action of SAFF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem., 1994, 219(1-2), 699-705.
52. Chikindas, M. L.; Novak, J.; Driessen, A. J.; Konings, W. N.; Schilling, K. M.; Caufield, P. W. Mutacin II, a bactericidal antibiotic from Streptococcus mutans. Antimicrob. Agents Chemother, 1995, 39(12), 2656-2660.
53. Wiedemann, I.; Böttiger, T.; Bonelli, R. R.; Schneider, T.; Sahl H.- G.; Martínez, B. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl. Environ. Microbiol., 2006, 72(4), 2809-2814
54. Asaduzzaman, S. M.; Nagao, J.; Iida, H.; Zendo, T.; Nakayama, J.; Sonomoto, K. Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob. Agents Chemother., 2009, 53(8), 3595-3598.
55. Sashihara, T.; Kimura, H.; Higuchi, T.; Adachi, A.; Matsusaki, H.; Sonomoto, K.; Ishizaki, A. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci. Biotechnol. Biochem., 2000, 64(11), 2420-2428.
56. Aso, Y.; Sashihara, T.; Nagao, J.; Kanemasa, Y.; Koga, H.; Hashimoto, T.; Higuchi, T.; Adachi, A.; Nomiyama, H.; Ishizaki, A.; Nakayama, J.; Sonomoto, K. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1. Biosci. Biotechnol. Biochem., 2004, 68(8), 1663-1671.
57. Islam, M. R.; Shioya, K.; Nagao, J.; Nishie, M.; Jikuya, H.; Zendo, T.; Nakayama, J.; Sonomoto, K. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning. Mol. Microbiol., 2009, 72(6), 1438-1447.
58. Szekat, C.; Jack, R. W.; Skutlarek, D.; Farber, H.; Bierbaum, G. Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Appl. Environ. Microbiol., 2003, 69(7), 3777-3783.
59. Nagao, J.; Harada, Y.; Shioya, K.; Aso, Y.; Zendo, T.; Nakayama, J.; Sonomoto, K. Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli. Biochem. Biophys. Res. Commun., 2005, 336(2), 507-513.
60. Shioya, K.; Harada, Y.; Nagao, J.; Nakayama, J.; Sonomoto, K. Characterization of modification enzyme NukM and engineering of a novel thioether bridge in lantibiotic nukacin ISK-1. Appl. Microbiol. Biotechnol., 2010, 86(3), 891-899.
61. Nishie, M.; Shioya, K.; Nagao, J.; Jikuya, H.; Sonomoto, K. ATPdependent leader peptide cleavage by NukT, a bifunctional ABC transporter, during lantibiotic biosynthesis. J. Biosci. Bioeng., 2009, 108(6), 460-464.
62. Levengood, M. R.; Kerwood, C. C.; Chatterjee, C.; van der Donk, W. A. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids. Chembiochem, 2009, 10(5), 911-919.
63. Levengood, M. R.; Knerr, P. J.; Oman, T. J.; van der Donk, W. A. In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids. J. Am. Chem. Soc., 2009, 131(34), 12024-12025.
64. Zhang, X.; van der Donk, W. A. On the substrate specificity of dehydration by lacticin 481 synthetase. J. Am. Chem. Soc., 2007, 129(8), 2212-2213.
65. You, Y. O.; van der Donk, W. A. Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis. Biochemistry, 2007, 46(20), 5991-6000.
66. Furgerson Ihnken, L. A.; Chatterjee, C.; van der Donk, W. A. In vitro reconstitution and substrate specificity of a lantibiotic protease. Biochemistry, 2008, 47(28), 7352-7363.
67. Bierbaum, G.; Sahl, H.-G. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol., 2009, 10(1), 2-18.